These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3080735)

  • 1. A prospective study on the incidence of liver function abnormalities in children receiving erythromycin estolate, erythromycin ethylsuccinate or penicillin V for treatment of pneumonia.
    Ginsburg CM
    Pediatr Infect Dis; 1986; 5(1):151-3. PubMed ID: 3080735
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatotoxicity to both erythromycin estolate and erythromycin ethylsuccinate.
    Keeffe EB; Reis TC; Berland JE
    Dig Dis Sci; 1982 Aug; 27(8):701-4. PubMed ID: 6980110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of beta hemolytic streptococcal pharyngitis. Comparison of amoxicillin, erythromycin estolate, and penicillin V.
    Breese BB; Disney FA; Green JL; Talpey WB
    Clin Pediatr (Phila); 1977 May; 16(5):460-3. PubMed ID: 403044
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hepatitis caused by various derivatives of erythromycin].
    Funck-Brentano C; Pessayre D; Benhamou JP
    Gastroenterol Clin Biol; 1983 Apr; 7(4):362-9. PubMed ID: 6347792
    [No Abstract]   [Full Text] [Related]  

  • 5. Five days of erythromycin estolate versus ten days of penicillin V in the treatment of group A streptococcal tonsillopharyngitis in children. Pharyngitis Study Group.
    Adam D; Scholz H
    Eur J Clin Microbiol Infect Dis; 1996 Sep; 15(9):712-7. PubMed ID: 8922570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of an oral erythromycin product.
    Fraser DG
    Am J Hosp Pharm; 1980 Sep; 37(9):1199-205. PubMed ID: 6998290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythromycin propionate and estolate.
    Farre M
    Lancet; 1988 Jul; 2(8601):45. PubMed ID: 2898648
    [No Abstract]   [Full Text] [Related]  

  • 8. Erythromycin therapy for group A streptococcal pharyngitis. Results of a comparative study of the estolate and ethylsuccinate formulations.
    Ginsburg CM; McCracken GH; Crow SD; Dildy BR; Morchower G; Steinberg JB; Lancaster K
    Am J Dis Child; 1984 Jun; 138(6):536-9. PubMed ID: 6372437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On the article of J. Buchanec and V. Kdrajnák: Lesions of the liver during therapy with erythromycin in 3 children].
    Rouzica M; Filipová K
    Cesk Pediatr; 1975 Jan; 30(1-2):71. PubMed ID: 1132045
    [No Abstract]   [Full Text] [Related]  

  • 10. [Erythromycin-induced hepatitis].
    Perrier M; Portier G; de Calan L; Favre JP; Ozoux JP; Rivallain B; Brizon J
    Cah Anesthesiol; 1987; 35(3):237. PubMed ID: 3621021
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatotoxicity of erythromycin derivatives.
    Pessayre D; Benhamou JP
    Br Med J; 1979 May; 1(6174):1357. PubMed ID: 445081
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA begins proceedings to remove erythromycin estolate from market.
    FDA Drug Bull; 1979 Nov; 9(5):26-7. PubMed ID: 510836
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk-benefit equation for erythromycin estolate.
    LeBel M
    Am J Hosp Pharm; 1980 Feb; 37(2):176, 180. PubMed ID: 7361788
    [No Abstract]   [Full Text] [Related]  

  • 14. Case study: Drug interference in clinical chemistry.
    Hansen JL; Swanson LN
    Am J Med Technol; 1981 Mar; 47(3):189-91. PubMed ID: 7223765
    [No Abstract]   [Full Text] [Related]  

  • 15. Erythromycin estolate-induced hepatitis. Ultrastructural study of liver.
    Gafter U; Mandel EM; Weiss S; Djaldetti M
    N Y State J Med; 1979 Jan; 79(1):87-9. PubMed ID: 282477
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of erythromycin estolate and erythromycin ethylsuccinate for treatment of pertussis. The Erythromycin Study Group.
    Hoppe JE
    Pediatr Infect Dis J; 1992 Mar; 11(3):189-93. PubMed ID: 1565532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Erythromycin].
    Simmen HP; Siegenthaler W; Lüthy R
    Dtsch Med Wochenschr; 1982 Oct; 107(39):1480-2. PubMed ID: 7117164
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetics of erythromycin ethylsuccinate and estolate in infants under 4 months of age.
    Patamasucon P; Kaojarern S; Kusmiesz H; Nelson JD
    Antimicrob Agents Chemother; 1981 May; 19(5):736-9. PubMed ID: 6975059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cholestatic hepatitis caused by erythromycin estolate].
    García Monzón C; Noguerado A; Hidalgo S; Escudero V
    Rev Clin Esp; 1985 Nov; 177(8):420-1. PubMed ID: 3836470
    [No Abstract]   [Full Text] [Related]  

  • 20. ERYTHROMYCIN ESTOLATE AND PHENOXYMETHYL PENICILLIN IN THE TREATMENT OF STREPTOCOCCAL PHARYNGITIS.
    MOFFETT HL; CRAMBLETT HG; BLACK JP; SHULENBERGER H; SMITH A; WILLIAMS AY
    Antimicrob Agents Chemother (Bethesda); 1963; 161():759-64. PubMed ID: 14275000
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.